• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 2000

View Archived Issues

Phase II results reported for tenofovir DF

Read More

Pivotal trial of Fabrazyme meets primary endpoint

Read More

Medarex and Centocor sign antibody development agreement

Read More

Transgenic antibody production agreement signed by Genzyme Transgenics and Abgenix

Read More

LigoCyte awarded Phase II SBIR grant for nanoparticle technology

Read More

Connetics continues to expand relaxin indications

Read More

Corixa expands technology through five new collaborative agreements

Read More

Q1 2000 marked by significant achievements at Elan

Read More

AxyS makes considerable progress in drug discovery and development programs during Q1 2000

Read More

Anti-human CD40 antibodies designed by BMS for use in immune disorders and inflammation

Read More

Final results of phase I/IIa trial evaluating CAT-152 in trabeculectomy patients announced at ARVO

Read More

Isis prepares antisense modulators of FAN expression

Read More

Schering prepares new fluorescent contrast agents for imaging tumors and blood vessels

Read More

News from ARVO: ISV-205 reduces corticosteroid-induced IOP elevations

Read More

Novel antifungal agent derived from BPI under study at Xoma

Read More

Tau protein kinase 1 inhibitors in development at Mitsubishi-Tokyo Pharmaceuticals

Read More

Oxazolidines and thiazolidines claimed by Roche Diagnostics for bone disorders

Read More

Preparation and biological evaluation of Cubist's new tRNA synthetase inhibitors described

Read More

New heterocyclic compounds from Procter & Gamble particularly useful for alopecia

Read More

Profile of KUL-7211, a new beta-adrenoceptor agonist with selectivity for ureteral smooth muscle

Read More

Actin polymerization inducer jasplakinolide improves outflow facility in primate model

Read More

Early clinical trial results in BPH suggest promise of new highly selective alpha1A blocker

Read More

A-204176 may increase IUP without cardiovascular side effects according to preclinical data

Read More

Clinical development of Neotrofin for AD reviewed at recent symposium

Read More

Celecoxib examined for effects on progression of AD in elderly in a 52-week study

Read More

Novel antiinflammatory drug tested in Sweden for efficacy in Alzheimer's disease

Read More

Nucleoside analogues with activity against herpesviruses developed by Japanese research team

Read More

No consistent cognitive or motor effects detected for SIB-1508Y in safety study in early PD

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 13, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 13, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe